Integrated Filing — IndAS



General information about company

Scrip Code 544222
NSE Symbol AKUMS
MSEI Symbol NOTLISTED
ISIN INE09XN01023
Name of company Akums Drugs and Pharmaceuticals Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 14-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 11-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Pharmaceuticals
Start date and time of board meeting 14-05-2026   11:30:00
End date and time of board meeting 14-05-2026   13:09:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. NA
Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 26-05-2025
Indicate Company website link for updated RPT policy of the Company https://www.akums.in/investors/disclosures-under-regulation-46-of-sebi-lodr/
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There is no default on loan and debt securities as on 31.03.2026



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
1 Income
Revenue from operations 33,837.20 1,34,873.60
Other income 2,772.90 11,296.50
Total income 36,610.10 1,46,170.10
2 Expenses
(a) Cost of materials consumed 21,280.90 83,034.20
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (614.50) (325.80)
(d) Employee benefit expense 5,787.80 21,799.30
(e) Finance costs 259.30 1,003.80
(f) Depreciation, depletion and amortisation expense 1,242.10 4,550.30
(f) Other Expenses
1 Other Expenses 6,204.30 20,619.90
Total other expenses 6,204.30 20,619.90
Total expenses 34,159.90 1,30,681.70
3 Total profit before exceptional items and tax 2,450.20 15,488.40
4 Exceptional items (271.10) (651.90)
5 Total profit before tax 2,179.10 14,836.50
6 Tax expense
7 Current tax 326.60 3,640.10
8 Deferred tax 332.80 32.40
9 Total tax expenses 659.40 3,672.50
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,519.70 11,164.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 1,519.70 11,164.00
17 Other comprehensive income net of taxes 82.40 46.50
18 Total Comprehensive Income for the period 1,602.10 11,210.50
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 3,062.10 3,062.10
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 0.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 0.99 7.29
Diluted earnings (loss) per share from continuing operations 0.99 7.29
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 0.99 7.29
Diluted earnings (loss) per share from continuing and discontinued operations 0.99 7.29
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Assets
1 Non-current assets
Property, plant and equipment 40,353.20
Capital work-in-progress 5,156.70
Investment property 1,811.30
Goodwill 0.00
Other intangible assets 339.60
Intangible assets under development 66.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 36,601.70
Trade receivables, non-current 0.00
Loans, non-current 60,847.80
Other non-current financial assets
1 Other non-current financial assets 913.80
Total of other non-current financial assets 913.80
Total non-current financial assets 98,363.30
Deferred tax assets (net)
Other non-current assets
1 Other non-current and tax assets 2,808.00
Total of other non-current assets 2,808.00
Total non-current assets 1,48,898.10
2 Current assets
Inventories 22,992.60
Current financial asset
Current investments 0.00
Trade receivables, current 21,754.20
Cash and cash equivalents 4,638.40
Bank balance other than cash and cash equivalents 72,456.00
Loans, current 0.00
Other current financial assets
Total of other current financial assets 2,326.30
Total current financial assets 1,01,174.90
Current tax assets (net)
Other current assets
1 Other current assets 8,182.20
Total of other current assets 8,182.20
Total current assets 1,32,349.70
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 2,81,247.80
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 3,062.10
Other equity 2,39,694.60
Total equity attributable to owners of parent 2,42,756.70
Non controlling interest
Total equity 2,42,756.70
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other non-current financial liabilities 1,266.60
2 Lease Liability 4,392.90
Total of other non-current financial liabilities 5,659.50
Total non-current financial liabilities 5,659.50
Provisions, non-current 1,637.60
Deferred tax liabilities (net) 794.50
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 8,091.60
Current liabilities
Current financial liabilities
Borrowings, current 1,355.20
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 2,871.40
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 17,269.00
Total Trade payable 20,140.40
Other current financial liabilities
1 Other current financial liabilities 6,324.40
2 Lease Liability 173.30
Total of other current financial liabilities 6,497.70
Total current financial liabilities 27,993.30
Other current liabilities 1,369.30
1 Other current liabilities 1,369.30
Total of other current liabilities 1,369.30
Provisions, current 798.80
Current tax liabilities (Net) 238.10
Deferred government grants, Current 0.00
Total current liabilities 30,399.50
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 38,491.10
Total equity and liabilites 2,81,247.80
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
Total Amount of items that will not be reclassified to profit and loss
2 Income tax relating to items that will not be reclassified to profit or loss (110.10) (62.10)
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 27.70 15.60
5 Total Other comprehensive income 82.40 46.50



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 14,836.50
Adjustments for reconcile profit (loss)
Adjustments for finance costs 1,003.80
Adjustments for decrease (increase) in inventories (2,823.70)
Adjustments for decrease (increase) in trade receivables, current (2,814.20)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (3,271.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 267.80
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (767.00)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 421.50
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 4,550.30
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 634.30
Adjustments for other financial liabilities, current 574.30
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 0.00
Adjustments for dividend income 0.00
Adjustments for interest income 10,073.30
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) (391.70)
Other adjustments for non-cash items 1,722.60
Share of profit and loss from partnership firm or association of persons or limited liability partnerships (500.60)
Total adjustments for reconcile profit (loss) (11,466.90)
Net cash flows from (used in) operations 3,369.60
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 3,569.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (199.40)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.30
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 0.00
Purchase of property, plant and equipment 12,207.20
Proceeds from sales of investment property 107.60
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 40,627.40
Cash advances and loans made to other parties 49,932.10
Cash receipts from repayment of advances and loans made to other parties 93,237.40
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 6,533.70
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 391.70
Net cash flows from (used in) investing activities (2,496.60)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 962.20
Repayments of borrowings 0.00
Payments of lease liabilities 273.20
Dividends paid 0.00
Interest paid 1,003.80
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (314.80)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (3,010.80)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (3,010.80)
Cash and cash equivalents cash flow statement at beginning of period 7,649.20
Cash and cash equivalents cash flow statement at end of period 4,638.40





Amount in (Lakhs)

Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)
Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity/subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Loan given 17,752.50 Exempted 4,776.00 29,172.00 33,068.00 Loan 7.2500 Upto March 2031 Unsecured Business purpose
2 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Loan repaid 4,000.00 Exempted 880.00 0.00 0.00
3 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Interest received 2,295.40 Exempted 1,142.70 161.00 180.80
4 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 50.00 Exempted 11.10 0.00 0.00
5 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Sale of goods or services 503.10 Exempted 20.50 5.90 13.50
6 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Sale of Property, Plant and Equipment 70.00 Exempted 0.70 0.00 0.00
7 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Service Income 50.00 Exempted (2.30) 0.00 0.00
8 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Purchase of goods or services 2,000.00 Exempted 93.80 9.90 15.60
9 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Expense incurred 25.00 Exempted 0.20 0.00 0.00
10 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment 200.00 Exempted 6.50 0.00 0.00
11 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Ltd. Wholly owned subsidiary Any other transaction Corporate Guarantee Charges 50.00 Exempted 2.50 0.00 0.00
12 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Loan given 64,441.80 Exempted 15,964.00 16,618.00 16,290.00 Loan 7.2500 Upto March 2031 Unsecured Business purpose
13 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Loan repaid 60,802.50 Exempted 16,292.00 0.00 0.00
14 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Interest received 3,593.50 Exempted 563.60 89.60 88.40
15 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 103.80 Exempted 42.40 0.00 0.00
16 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Rent Received 300.00 Exempted 93.10 0.00 0.00
17 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Sale of goods or services 1,533.10 Exempted 823.50 66.90 158.50
18 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Job Work Charges 1,061.10 Exempted 562.20 0.00 0.00
19 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Purchase of goods or services 5,813.00 Exempted 2,492.20 227.70 223.40
20 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment 200.00 Exempted 3.60 0.00 0.00
21 Akums Drugs and Pharmaceuticals Ltd. Malik Lifesciences Pvt. Ltd. Wholly owned subsidiary Any other transaction Sale of Property, Plant and Equipment 70.00 Exempted 1.10 0.00 0.00
22 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Loan given 31,432.50 Exempted 9,168.00 0.00 0.00 Loan 7.2500 Upto March 2031 Unsecured Business purpose
23 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Loan repaid 31,696.50 Exempted 9,168.00 0.00 0.00
24 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Interest received 1,390.40 Exempted 5.50 1.10 2.60
25 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 100.00 Exempted 28.20 0.00 0.00
26 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Rent Received 100.00 Exempted 28.30 0.00 0.00
27 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Sales of RODTEP scrips 50.00 Exempted 1.20 0.00 0.00
28 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Sale of goods or services 508.40 Exempted 16.10 21.30 18.80
29 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Purchase of goods or services 17,299.90 Exempted 5,491.20 644.90 1,694.70
30 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment 200.00 Exempted 62.80 0.00 0.00
31 Akums Drugs and Pharmaceuticals Ltd. Maxcure Nutravedics Ltd. Wholly owned subsidiary Any other transaction Sale of Property, Plant and Equipment 50.00 Exempted 0.60 0.00 0.00
32 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 25.00 Exempted 2.20 0.00 0.00
33 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Sale of goods or services 509.70 Exempted 270.50 109.90 163.40
34 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Service Income 50.00 Exempted 2.00 0.00 0.00
35 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Corporate Guarantee Charges 50.00 Exempted 6.00 0.00 0.00
36 Akums Drugs and Pharmaceuticals Ltd. Nicholas Healthcare Ltd. Wholly owned subsidiary Any other transaction Expenses incurred 25.00 Exempted 0.30 0.00 0.00
37 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Corporate Guarantee Charges 50.00 Exempted 2.50 0.00 0.00
38 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 25.00 Exempted 2.40 0.00 0.00
39 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Expenses incurred 25.00 Exempted 4.30 0.00 0.00
40 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Sale of goods or services 702.50 Exempted 421.40 276.20 339.70
41 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Service Income 50.00 Exempted 0.10 0.00 0.00
42 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Purchase of goods or services 50.00 Exempted 0.80 0.00 0.90
43 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment 25.00 Exempted 14.50 0.00 0.00
44 Akums Drugs and Pharmaceuticals Ltd. Plenteous Pharmaceuticals Ltd. Wholly owned subsidiary Any other transaction Security deposit repaid 0.00 Exempted 7.80 7.80 0.00
45 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Loan given 1,20,000.00 Exempted 9,214.00 80.00 3,450.00 Loan 7.2500 Upto March 2031 Unsecured Business purpose
46 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Loan repaid 1,19,546.10 Exempted 5,844.00 0.00 0.00
47 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Interest received 8,039.20 Exempted 6.80 0.40 1.90
48 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 203.10 Exempted 122.20 0.00 0.00
49 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Rent Received 200.00 Exempted 64.50 0.00 0.00
50 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Sale of goods or services 7,031.00 Exempted 1,375.90 180.70 520.00
51 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Sale of Property, Plant and Equipment 500.00 Exempted 18.00 0.00 0.00
52 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Service Income 13,050.00 Exempted 287.50 0.00 0.00
53 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Expenses paid by other Group Company 102.50 Exempted 2.10 0.00 0.00
54 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Job Work Charges 4,032.50 Exempted 1,077.60 0.00 0.00
55 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Purchase of goods or services 14,307.70 Exempted 2,936.70 335.50 1,393.50
56 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment 1,000.00 Exempted 13.90 0.00 0.00
57 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Job Work Income 203.20 Exempted 87.60 0.00 0.00
58 Akums Drugs and Pharmaceuticals Ltd. Pure & Cure Healthcare Pvt. Ltd. Wholly owned subsidiary Any other transaction Expenses Incurred 25.00 Exempted 0.20 0.00 0.00
59 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 50.00 Exempted 8.10 0.00 0.00
60 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Purchase of goods or services 25.00 Exempted 0.00 0.00 0.60
61 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Any other transaction Purchase of Property, Plant and Equipment 25.00 Exempted 0.50 0.00 0.00
62 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Sale of goods or services 14,054.30 Exempted 4,430.80 1,891.20 3,093.50
63 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Any other transaction Service Income 150.00 Exempted 19.00 0.00 0.00
64 Akums Drugs and Pharmaceuticals Ltd. Unosource Pharma Ltd. Wholly owned subsidiary Any other transaction Corporate Guarantee Charges 50.00 Exempted 10.00 0.00 0.00
65 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Controlled LLP (100%) Any other transaction Loan given 2,000.00 Approved 0.00 1,389.00 1,389.00 Loan 7.2500 Upto March 2031 Unsecured Business purpose
66 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Controlled LLP (100%) Interest received 193.50 Approved 51.10 40.90 61.60
67 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Controlled LLP (100%) Any other transaction Expense incurred on behalf of Company 50.00 Approved 5.70 0.00 0.00
68 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Controlled LLP (100%) Sale of goods or services 200.00 Approved 7.60 17.50 16.70
69 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Controlled LLP (100%) Any other transaction Sale of Property, Plant and Equipment 50.00 Approved 3.40 0.00 0.00
70 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Controlled LLP (100%) Any other transaction Consumption of stores and spare parts 2,057.40 Approved 267.90 0.00 0.00
71 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Controlled LLP (100%) Purchase of goods or services 835.90 Approved 319.80 88.60 50.40
72 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Controlled LLP (100%) Any other transaction Purchase of Property, Plant and Equipment 200.00 Approved 0.40 0.00 0.00
73 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Controlled LLP (100%) Any other transaction Repairs and maintenance- Plant and machinery 500.00 Approved 116.50 0.00 0.00
74 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Controlled LLP (100%) Any other transaction Job Work Charges 100.00 Approved 5.90 0.00 0.00
75 Akums Drugs and Pharmaceuticals Ltd. Upadhrish Reserchem LLP Controlled LLP (100%) Any other transaction Share of profit from Partnership firm/ LLP 2,000.00 Approved 312.30 1,419.30 1,731.60
76 Akums Drugs and Pharmaceuticals Ltd. May and Baker Pharmaceuticals Ltd. Entity in which KMP/ relatives of KMP are interested Sale of goods or services 676.80 Approved 7.60 5.30 2.50
77 Akums Drugs and Pharmaceuticals Ltd. May and Baker Pharmaceuticals Ltd. Entity in which KMP/ relatives of KMP are interested Purchase of goods or services 25.00 Approved 0.00 0.10 0.00
78 Akums Drugs and Pharmaceuticals Ltd. May and Baker Pharmaceuticals Ltd. Entity in which KMP/ relatives of KMP are interested Any other transaction Expenses paid by other Group Company 25.00 Approved 0.20 0.00 0.00
79 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Sale of goods or services 500.00 Exempted 6.10 6.50 7.70
80 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 25.00 Exempted 1.30 0.00 0.00
81 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Service Income 50.00 Exempted 1.80 0.00 0.00
82 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Corporate Guarantee Charges 50.00 Exempted 4.50 0.00 0.00
83 Akums Drugs and Pharmaceuticals Ltd. Medibox Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Security deposit received 0.00 Exempted 0.00 26.80 26.80
84 Akums Drugs and Pharmaceuticals Ltd. Akumentis Healthcare Limited Subsidiary Sale of goods or services 3,972.40 Exempted 998.60 495.00 393.50
85 Akums Drugs and Pharmaceuticals Ltd. Akumentis Healthcare Limited Subsidiary Any other transaction Service Income 101.30 Exempted 5.40 0.00 0.00
86 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Loan given 20,000.00 Exempted 495.00 5,827.10 6,217.10 Loan 7.2500 Upto May 2028 Unsecured Business purpose
87 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Loan repaid 500.00 Exempted 105.00 0.00 0.00
88 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Sale of goods or services 500.00 Exempted 0.30 0.10 3.10
89 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Purchase of goods or services 1,000.00 Exempted 46.50 8.90 18.10
90 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Expense incurred on behalf of Company 200.00 Exempted 2.80 0.00 0.00
91 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Interest received 1,706.60 Exempted 221.70 32.20 34.40
92 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Rent Paid 50.00 Exempted 18.30 0.00 0.00
93 Akums Drugs and Pharmaceuticals Ltd. Qualymed Pharma Pvt. Ltd. Wholly owned subsidiary Any other transaction Expenses paid by other Group Company 50.00 Exempted 20.60 0.00 0.00
94 Akums Drugs and Pharmaceuticals Ltd. Akums Health and Education Society Entity in which KMP/ relatives of KMP are interested Sale of goods or services 200.00 Approved 0.20 0.00 0.00
95 Akums Drugs and Pharmaceuticals Ltd. Akums Foundation Entity in which KMP/ relatives of KMP are interested Sale of goods or services 200.00 Approved 0.00 0.10 0.00
96 Akums Drugs and Pharmaceuticals Ltd. Akums Foundation Entity in which KMP/ relatives of KMP are interested Any other transaction CSR Contribution 2,000.00 Approved 128.80 0.00 0.00
97 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt. Ltd. Entity in which KMP/ relatives of KMP are interested Any other transaction Rent Paid 350.00 Approved 119.20 0.00 0.00
98 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt. Ltd. Entity in which KMP/ relatives of KMP are interested Any other transaction Expense incurred on behalf of Company 25.00 Approved 2.50 0.00 0.00
99 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt. Ltd. Entity in which KMP/ relatives of KMP are interested Purchase of goods or services 423.90 Approved 177.50 16.10 19.40
100 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt. Ltd. Entity in which KMP/ relatives of KMP are interested Sale of goods or services 200.00 Approved 0.00 1.80 0.90
101 Akums Drugs and Pharmaceuticals Ltd. Akome Lifecare Pvt. Ltd. Entity in which KMP/ relatives of KMP are interested Any other transaction Expenses paid by other Group Company 86.90 Approved 20.80 0.00 0.00
102 Akums Drugs and Pharmaceuticals Ltd. Akums Employee Benefit Trust Trust whose Board of Directors is accustomed to act in accordance with the advice, directions or instructions of Managing Directors of Akums Any other transaction Loan given Approved 0.50 30,043.50 30,044.00 Loan 0 Interest free loan and its an Interest free loan Unsecured For acquisition of shares under ESOP scheme
103 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare UK Ltd Wholly owned subsidiary Any other transaction Loan given 100.00 Approved 60.70 0.00 62.80 Loan 7.2500 Upto December 2030 Unsecured Business purpose
104 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare UK Ltd Wholly owned subsidiary Interest received Approved 1.20 0.00 1.20
105 Akums Drugs and Pharmaceuticals Ltd. Akums Healthcare Malta Pvt Ltd Wholly owned subsidiary Any other transaction Investment through acquisition of shares 0.30 Approved 0.30 0.00 0.00
106 Akums Drugs and Pharmaceuticals Ltd. Mr. Sanjeev Jain Managing Director Any other transaction Director remuneration Approved 472.20 30.00 137.00
107 Akums Drugs and Pharmaceuticals Ltd. Mr. Sanjeev Jain Managing Director Any other transaction Rent Paid Approved 4.70 0.00 0.00
108 Akums Drugs and Pharmaceuticals Ltd. Mr. Sanjeev Jain Managing Director Any other transaction Refund of excess IPO expenses Approved 0.00 0.00 67.90
109 Akums Drugs and Pharmaceuticals Ltd. Mr. Sandeep Jain Managing Director Any other transaction Director remuneration Approved 467.90 30.00 137.00
110 Akums Drugs and Pharmaceuticals Ltd. Mr. Sandeep Jain Managing Director Any other transaction Rent Paid Approved 12.50 0.00 0.00
111 Akums Drugs and Pharmaceuticals Ltd. Mr. Sandeep Jain Managing Director Any other transaction Refund of excess IPO expenses Approved 0.00 0.00 67.90
112 Akums Drugs and Pharmaceuticals Ltd. Mr. Kewal Handa Independent Director Any other transaction Legal & professional charges Approved 20.00 0.00 0.00
113 Akums Drugs and Pharmaceuticals Ltd. Ms. Matangi Gowrishankar Independent Director Any other transaction Expenses incurred Approved 0.00 0.00 0.00
114 Akums Drugs and Pharmaceuticals Ltd. Ms. Matangi Gowrishankar Independent Director Any other transaction Legal & professional charges Approved 15.00 0.00 0.00
115 Akums Drugs and Pharmaceuticals Ltd. Mr. Anilkumar Arvindlal Amin Independent Director Any other transaction Legal & professional charges Approved 20.00 0.00 0.00
116 Akums Drugs and Pharmaceuticals Ltd. Mr. Anilkumar Arvindlal Amin Independent Director Any other transaction Expenses incurred Approved 8.00 0.00 0.00
117 Akums Drugs and Pharmaceuticals Ltd. Ms. Arushi Jain Relatives of KMP Any other transaction Remuneration Approved 42.00 5.00 5.00
118 Akums Drugs and Pharmaceuticals Ltd. Mr. Umang Jain Relatives of KMP Any other transaction Remuneration Approved 16.60 2.20 2.20
119 Akums Drugs and Pharmaceuticals Ltd. Ms. Shivangi Jain Relatives of KMP Any other transaction Remuneration Approved 16.60 2.20 2.20
120 Akumentis Healthcare Limited Akums Healthcare Ltd. Fellow subsidiary Purchase of goods or services 100.00 Approved 447.20 35.20 65.80
121 Akumentis Healthcare Limited Malik Lifesciences Pvt. Ltd. Fellow subsidiary Purchase of goods or services 1,500.00 Approved 254.10 123.50 25.10
122 Akumentis Healthcare Limited Malik Lifesciences Pvt. Ltd. Fellow subsidiary Any other transaction Expenses incurred 25.00 Approved 0.20 0.00 0.00
123 Akumentis Healthcare Limited Maxcure Nutravedics Ltd. Fellow subsidiary Purchase of goods or services 500.00 Approved 282.30 86.20 47.80
124 Akumentis Healthcare Limited Maxcure Nutravedics Ltd. Fellow subsidiary Any other transaction Expenses incurred 25.00 Approved 0.30 0.00 0.00
125 Akumentis Healthcare Limited Nicholas Healthcare Ltd. Fellow subsidiary Any other transaction Loan given 3,000.00 Approved 0.00 475.00 375.00 Loan 8.2500 Upto January 2028 Unsecured Business purpose
126 Akumentis Healthcare Limited Nicholas Healthcare Ltd. Fellow subsidiary Any other transaction Loan repaid 1,000.00 Approved 100.00 0.00 0.00
127 Akumentis Healthcare Limited Nicholas Healthcare Ltd. Fellow subsidiary Interest received 302.00 Approved 15.10 2.60 2.10
128 Akumentis Healthcare Limited Nicholas Healthcare Ltd. Fellow subsidiary Purchase of goods or services 1,500.00 Approved 9.10 5.70 0.00
129 Akumentis Healthcare Limited Plenteous Pharmaceuticals Ltd. Fellow subsidiary Any other transaction Loan given 5,000.00 Approved 0.00 4,159.30 4,079.30 Loan 8.2500 Upto January 2028 Unsecured Business purpose
130 Akumentis Healthcare Limited Plenteous Pharmaceuticals Ltd. Fellow subsidiary Any other transaction Loan repaid 1,000.00 Approved 80.00 0.00 0.00
131 Akumentis Healthcare Limited Plenteous Pharmaceuticals Ltd. Fellow subsidiary Interest received 759.00 Approved 154.00 46.90 0.00
132 Akumentis Healthcare Limited Plenteous Pharmaceuticals Ltd. Fellow subsidiary Sale of goods or services 100.00 Approved 0.00 5.70 11.80
133 Akumentis Healthcare Limited Plenteous Pharmaceuticals Ltd. Fellow subsidiary Any other transaction Royalty Income 100.00 Approved 16.60 0.00 0.00
134 Akumentis Healthcare Limited Pure & Cure Healthcare Pvt. Ltd. Fellow subsidiary Purchase of goods or services 4,000.00 Approved 1,449.80 814.90 446.60
135 Akumentis Healthcare Limited Pure & Cure Healthcare Pvt. Ltd. Fellow subsidiary Any other transaction Expenses Incurred 25.00 Approved 8.80 0.00 0.00
136 Akumentis Healthcare Limited Unosource Pharma Ltd. Fellow subsidiary Any other transaction Loan given 5,000.00 Approved 0.00 3,700.00 1,910.00 Loan 8.2500 Upto January 2028 Unsecured Business purpose
137 Akumentis Healthcare Limited Unosource Pharma Ltd. Fellow subsidiary Interest received 783.80 Approved 89.60 21.50 10.90
138 Akumentis Healthcare Limited Unosource Pharma Ltd. Fellow subsidiary Any other transaction Loan repaid 1,000.00 Approved 1,790.00 0.00 0.00
139 Akumentis Healthcare Limited Upadhrish Reserchem LLP Fellow subsidiary Purchase of goods or services 50.00 Approved 0.00 2.50 6.10
140 Akumentis Healthcare Limited Upadhrish Reserchem LLP Fellow subsidiary Any other transaction Expenses Incurred 150.00 Approved 14.90 0.00 0.00
141 Akumentis Healthcare Limited Medibox Pharma Pvt. Ltd. Fellow subsidiary Any other transaction Loan given 5,000.00 Approved 0.00 2,807.00 2,691.80 Loan 8.2500 Upto January 2028 Unsecured Business purpose
142 Akumentis Healthcare Limited Medibox Pharma Pvt. Ltd. Fellow subsidiary Any other transaction Loan repaid 1,000.00 Approved 115.20 0.00 0.00
143 Akumentis Healthcare Limited Medibox Pharma Pvt. Ltd. Fellow subsidiary Interest received 659.80 Approved 101.50 15.60 15.40
144 Akumentis Healthcare Limited Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services 100.00 Approved 0.00 0.20 0.00
145 Akumentis Healthcare Limited Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR contribution 500.00 Approved 56.90 0.00 0.00
146 Malik Lifesciences Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Purchase of goods or services Approved 275.90 119.40 52.10
147 Malik Lifesciences Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 56.40 9.50 16.20
148 Malik Lifesciences Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Expenses paid by other Group Company Approved 8.40 0.00 0.00
149 Malik Lifesciences Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services Approved 13.90 0.40 0.20
150 Malik Lifesciences Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Paid Approved 44.20 0.00 0.00
151 Malik Lifesciences Pvt. Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution Approved 5.50 0.00 0.00
152 Malik Lifesciences Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Any other transaction Expenses incurred Approved 0.00 0.00 0.00
153 Malik Lifesciences Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Purchase of goods or services Approved 8,233.70 790.20 2,603.80
154 Malik Lifesciences Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of fixed assets Approved 0.10 0.00 0.00
155 Malik Lifesciences Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of goods or services Approved 303.90 117.70 0.20
156 Malik Lifesciences Pvt. Ltd. Medibox Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 153.40 36.70 56.20
157 Malik Lifesciences Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Any other transaction Service Income Approved 0.10 0.00 0.00
158 Malik Lifesciences Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 327.90 198.10 195.90
159 Malik Lifesciences Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Sale of goods or services Approved 211.60 54.10 187.40
160 Malik Lifesciences Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Any other transaction Service Income Approved 0.10 0.00 0.00
161 Malik Lifesciences Pvt. Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Purchase of goods or services Approved 2.00 3.10 0.00
162 Malik Lifesciences Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Purchase of RODTEP scrips Approved 9.10 4.10 0.00
163 Malik Lifesciences Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Sale of goods or services Approved 559.40 426.40 510.00
164 Malik Lifesciences Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Service Income Approved 0.60 0.00 0.00
165 Malik Lifesciences Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Consumption of stores and spare parts Approved 51.00 0.00 0.00
166 Malik Lifesciences Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Repairs and maintenance- Plant and machinery Approved 30.40 0.00 0.00
167 Malik Lifesciences Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Purchase of goods or services Approved 47.80 25.60 (1.00)
168 Malik Lifesciences Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of fixed assets Approved 3.60 0.00 0.00
169 Malik Lifesciences Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Approved 0.00 0.00 4.30
170 Akums Healthcare Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services Approved 7.10 0.60 3.10
171 Akums Healthcare Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Paid Approved 1.00 0.00 0.00
172 Akums Healthcare Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services Approved 0.00 0.00 0.00
173 Akums Healthcare Ltd. Medibox Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 4.40 3.30 4.60
174 Akums Healthcare Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 6.30 10.10 6.60
175 Akums Healthcare Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Sale of goods or services Approved 10.80 0.00 7.30
176 Akums Healthcare Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Purchase of goods or services Approved 3.20 0.10 1.30
177 Akums Healthcare Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 0.00 0.50 0.00
178 Akums Healthcare Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Approved 0.10 0.00 0.00
179 Akums Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Consumption of stores and spare parts Approved 28.90 0.00 0.00
180 Akums Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Repairs and maintenance- Plant and machinery Approved 47.20 0.00 0.00
181 Akums Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Expenses incurred Approved (20.80) 0.00 0.00
182 Akums Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Purchase of goods or services Approved 33.30 12.50 7.60
183 Akums Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of fixed assets Approved 1.50 0.00 0.00
184 Akums Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Approved 0.00 36.60 1.90
185 Maxcure Nutravedics Ltd. Akums Healthcare Ltd. Fellow Subsidiary Purchase of goods or services Approved 7.90 0.00 9.40
186 Maxcure Nutravedics Ltd. Akums Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 71.50 (0.40) 37.50
187 Maxcure Nutravedics Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Expenses paid by other Group Company Approved 4.20 0.00 0.00
188 Maxcure Nutravedics Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services Approved 16.30 4.60 3.90
189 Maxcure Nutravedics Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Paid Approved 21.80 0.00 0.00
190 Maxcure Nutravedics Ltd. Akums Health and Education Society Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services Approved 0.60 0.00 0.00
191 Maxcure Nutravedics Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution Approved 24.90 0.00 0.00
192 Maxcure Nutravedics Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services Approved 0.00 1.00 0.00
193 Maxcure Nutravedics Ltd. Medibox Pharma Pvt. Ltd. Fellow Subsidiary Purchase of goods or services Approved 0.00 0.00 0.00
194 Maxcure Nutravedics Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Any other transaction Expenses incurred Approved (0.10) 0.00 0.00
195 Maxcure Nutravedics Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Purchase of goods or services Approved 0.00 0.10 (0.20)
196 Maxcure Nutravedics Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Any other transaction Expenses incurred Approved 0.00 0.00 0.00
197 Maxcure Nutravedics Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Purchase of goods or services Approved 0.00 0.10 0.00
198 Maxcure Nutravedics Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Purchase of goods or services Approved 3.70 0.60 2.90
199 Maxcure Nutravedics Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Purchase of RODTEP scrips Approved 21.00 0.00 0.00
200 Maxcure Nutravedics Ltd. Unosource Pharma Ltd. Fellow Subsidiary Sale of goods or services Approved 49.40 16.90 39.00
201 Maxcure Nutravedics Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Service Income Approved 0.00 0.00 0.00
202 Maxcure Nutravedics Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Consumption of stores and spare parts Approved 139.20 0.00 0.00
203 Maxcure Nutravedics Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Repairs and maintenance- Plant and machinery Approved 10.60 0.00 0.00
204 Maxcure Nutravedics Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Purchase of goods or services Approved 120.10 52.80 0.10
205 Maxcure Nutravedics Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of fixed assets Approved 0.70 0.00 0.00
206 Maxcure Nutravedics Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Approved 141.40 110.20 147.20
207 Medibox Pharma Pvt. Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services Approved 0.00 1.40 0.00
208 Medibox Pharma Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Approved 0.10 0.00 0.00
209 Medibox Pharma Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 0.00 1.30 0.00
210 Medibox Pharma Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Approved 0.10 0.00 0.00
211 Nicholas Healthcare Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Any other transaction Rent Received Approved 13.00 0.00 0.00
212 Nicholas Healthcare Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Expenses incurred Approved 2.50 0.00 0.00
213 Plenteous Pharmaceuticals Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Sale of goods or services Approved 0.00 2.20 0.00
214 Plenteous Pharmaceuticals Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Expenses incurred Approved 4.00 0.00 0.00
215 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Approved 0.20 0.00 0.00
216 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Purchase of fixed assets Approved 0.10 0.00 0.00
217 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Purchase of goods or services Approved 24.80 6.20 1.40
218 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Sale of fixed assets Approved 9.70 0.00 0.00
219 Pure & Cure Healthcare Pvt. Ltd. Akums Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 44.00 6.30 1.60
220 Pure & Cure Healthcare Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Expenses paid by other Group Company Approved 25.20 0.00 0.00
221 Pure & Cure Healthcare Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services Approved 96.10 22.60 8.20
222 Pure & Cure Healthcare Pvt. Ltd. Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction Rent Paid Approved 132.20 0.00 0.00
223 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Approved 0.20 0.00 0.00
224 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Purchase of fixed assets Approved 3.70 0.00 0.00
225 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Purchase of fixed assets Approved 6.20 0.50 0.70
226 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Sale of fixed assets Approved 76.90 0.00 0.00
227 Pure & Cure Healthcare Pvt. Ltd. Malik Lifesciences Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 418.30 205.60 171.60
228 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Any other transaction Expenses incurred Approved 0.00 0.00 0.00
229 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Approved 0.10 0.00 0.00
230 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Purchase of fixed assets Approved 0.70 0.00 0.00
231 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Purchase of goods or services Approved 8,625.00 1,635.30 1,995.70
232 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of fixed assets Approved 0.10 0.00 0.00
233 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Any other transaction Sales of RODTEP scrips Approved 16.00 0.00 0.00
234 Pure & Cure Healthcare Pvt. Ltd. Maxcure Nutravedics Ltd. Fellow Subsidiary Sale of goods or services Approved 146.40 5.80 103.00
235 Pure & Cure Healthcare Pvt. Ltd. Medibox Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 137.60 58.80 62.20
236 Pure & Cure Healthcare Pvt. Ltd. Medibox Pharma Pvt. Ltd. Fellow Subsidiary Any other transaction Service Income Approved 0.10 0.00 0.00
237 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Approved 0.20 0.00 0.00
238 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Purchase of fixed assets Approved 1.00 0.00 0.00
239 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Any other transaction Service Income Approved 8.30 0.00 0.00
240 Pure & Cure Healthcare Pvt. Ltd. Nicholas Healthcare Ltd. Fellow Subsidiary Sale of goods or services Approved 904.00 448.80 711.00
241 Pure & Cure Healthcare Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Sale of goods or services Approved 264.90 95.40 249.10
242 Pure & Cure Healthcare Pvt. Ltd. Plenteous Pharmaceuticals Ltd. Fellow Subsidiary Any other transaction Service Income Approved 0.20 0.00 0.00
243 Pure & Cure Healthcare Pvt. Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Purchase of goods or services Approved 201.20 54.70 53.80
244 Pure & Cure Healthcare Pvt. Ltd. Qualymed Pharma Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 0.00 0.30 0.00
245 Pure & Cure Healthcare Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Sale of goods or services Approved 0.00 0.00 0.00
246 Pure & Cure Healthcare Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Expense incurred on behalf of Company Approved 0.20 0.00 0.00
247 Pure & Cure Healthcare Pvt. Ltd. Unosource Pharma Ltd. Fellow Subsidiary Any other transaction Service Income Approved 0.30 0.00 0.00
248 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Consumption of stores and spare parts Approved 193.30 0.00 0.00
249 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Repairs and maintenance- Plant and machinery Approved 109.80 0.00 0.00
250 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Expenses incurred Approved 0.20 0.00 0.00
251 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Purchase of fixed assets Approved 3.20 0.00 0.00
252 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Purchase of goods or services Approved 604.80 54.50 21.00
253 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of fixed assets Approved 203.10 0.00 0.00
254 Pure & Cure Healthcare Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Approved 4.70 58.80 244.50
255 Pure & Cure Healthcare Pvt. Ltd. Sarvagunaushdhi Pvt. Ltd. Fellow Subsidiary Sale of goods or services Approved 0.00 952.70 938.20
256 Qualymed Pharma Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Purchase of goods or services Approved 0.00 0.00 0.00
257 Qualymed Pharma Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Any other transaction Repairs and maintenance- Plant and machinery Approved 1.30 0.00 0.00
258 Qualymed Pharma Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of goods or services Approved 0.10 0.00 0.60
259 Qualymed Pharma Pvt. Ltd. Upadhrish Reserchem LLP Fellow Subsidiary Sale of fixed assets Approved 0.50 0.00 0.00
260 Unosource Pharma Ltd. Akums Foundation Entities where significant influence is exercised by KMP and/or their relatives of holding company Any other transaction CSR Contribution Approved 30.50 0.00 0.00
261 Upadhrish Reserchem LLP Akome Lifecare Pvt. Ltd. Entities where significant influence is exercised by KMP and/or their relatives of holding company Purchase of goods or services Approved 0.00 0.00 0.00
262 Malik Lifesciences Pvt. Ltd. Mr. Sandeep Jain KMP in holding company Any other transaction Rent Paid Approved 1.20 0.00 0.00
263 Malik Lifesciences Pvt. Ltd. Ms. Archana Jain Relatives of KMP in holding Company Any other transaction Rent Paid Approved 0.50 0.00 0.00
264 Maxcure Nutravedics Ltd. Mr. Sandeep Jain KMP in holding company Any other transaction Rent Paid Approved 0.20 0.00 0.00
265 Maxcure Nutravedics Ltd. Ms. Lata Jain Relatives of KMP in holding Company Any other transaction Rent Paid Approved 0.20 0.00 0.00
266 Maxcure Nutravedics Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent Paid Approved 0.50 0.00 0.00
267 Pure & Cure Healthcare Pvt. Ltd. Mr. Sandeep Jain KMP in holding company Any other transaction Rent Paid Approved 2.70 0.00 0.00
268 Pure & Cure Healthcare Pvt. Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent Paid Approved 2.60 0.00 0.00
269 Pure & Cure Healthcare Pvt. Ltd. Ms. Lata Jain Relatives of KMP in holding Company Any other transaction Remuneration Approved 29.90 3.30 2.80
270 Maxcure Nutravedics Ltd. Ms. Archana Jain Relatives of KMP in holding Company Any other transaction Remuneration Approved 27.30 3.30 3.30
271 Akumentis Healthcare Limited Mr. Kanishk Jain Director Any other transaction Remuneration Approved 41.30 4.20 5.60
272 Akumentis Healthcare Limited Mr. Sanjeev Jain KMP in holding company Any other transaction Security deposit given Approved 0.00 50.00 50.00
273 Akumentis Healthcare Limited Mr. Sandeep Jain KMP in holding company Any other transaction Security deposit given Approved 0.00 50.00 50.00
274 Unosource Pharma Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent paid Approved 50.00 0.00 0.00
275 Unosource Pharma Ltd. Mr. Sandeep Jain KMP in holding company Any other transaction Rent paid Approved 50.00 0.00 0.00
276 Medibox Pharma Pvt. Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent paid Approved 0.00 0.00 0.00
277 Nicholas Healthcare Ltd. Mr. Sandeep Jain KMP in holding company Any other transaction Rent paid Approved 0.00 0.00 0.00
278 Sarvagunaushdhi Pvt. Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent paid Approved 0.00 0.00 0.00
279 Plenteous Pharmaceuticals Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent paid Approved 0.60 0.00 0.00
280 Akumentis Healthcare Limited Mr. Sanjeev Jain KMP in holding company Any other transaction Rent paid Approved 41.00 0.00 0.00
281 Akumentis Healthcare Limited Mr. Sandeep Jain KMP in holding company Any other transaction Rent paid Approved 41.00 0.00 0.00
282 Akumentis Healthcare Limited Ms. Lata Jain Relatives of KMP in holding Company Any other transaction Rent paid Approved 0.20 0.00 0.00
283 Akums Healthcare Ltd. Mr. Sanjeev Jain KMP in holding company Any other transaction Rent paid Approved 0.10 0.00 0.00
284 Qualymed Pharma Pvt. Ltd. Mr. Sandeep Jain KMP in holding company Any other transaction Rent paid Approved 1.90 0.00 0.00
285 Medibox Pharma Pvt. Ltd. Ms. Arushi Jain Relatives of KMP in holding Company Any other transaction Director sitting fees Approved 0.20 0.00 0.00
286 Upadhrish Reserchem LLP Mr. Sandeep Jain KMP in holding company Any other transaction Rent paid Approved 2.80 0.00 0.00
Total value of transaction during the reporting period 1,27,317.10